| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 51 | 2024 | 1629 | 5.190 |
Why?
|
| Physical Conditioning, Animal | 7 | 2022 | 354 | 2.200 |
Why?
|
| Heart | 21 | 2024 | 4464 | 2.040 |
Why?
|
| Ventricular Remodeling | 14 | 2022 | 1223 | 1.960 |
Why?
|
| Exercise | 12 | 2022 | 5615 | 1.950 |
Why?
|
| Cardiomegaly | 15 | 2024 | 620 | 1.790 |
Why?
|
| MicroRNAs | 14 | 2024 | 3751 | 1.600 |
Why?
|
| Heart Failure | 22 | 2024 | 10895 | 1.540 |
Why?
|
| Myocardium | 23 | 2021 | 4772 | 1.540 |
Why?
|
| Myocardial Reperfusion Injury | 8 | 2023 | 476 | 1.470 |
Why?
|
| Activins | 3 | 2024 | 208 | 1.210 |
Why?
|
| Immediate-Early Proteins | 4 | 2017 | 453 | 1.130 |
Why?
|
| Aging | 12 | 2020 | 8664 | 1.000 |
Why?
|
| Proto-Oncogene Proteins c-akt | 15 | 2011 | 2504 | 0.990 |
Why?
|
| Signal Transduction | 32 | 2020 | 23404 | 0.910 |
Why?
|
| Boidae | 1 | 2022 | 15 | 0.860 |
Why?
|
| Neovascularization, Physiologic | 9 | 2013 | 1351 | 0.840 |
Why?
|
| Oxygenases | 9 | 2001 | 60 | 0.780 |
Why?
|
| Myostatin | 4 | 2009 | 124 | 0.760 |
Why?
|
| Phosphatidylinositol 3-Kinases | 8 | 2014 | 2938 | 0.720 |
Why?
|
| Animals | 108 | 2024 | 168768 | 0.720 |
Why?
|
| Heart Diseases | 3 | 2024 | 2789 | 0.720 |
Why?
|
| Apoptosis | 22 | 2016 | 9724 | 0.710 |
Why?
|
| Stroke Volume | 8 | 2023 | 5006 | 0.640 |
Why?
|
| Activin Receptors, Type II | 1 | 2019 | 127 | 0.640 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 2022 | 235 | 0.640 |
Why?
|
| Fatty Liver | 2 | 2022 | 727 | 0.590 |
Why?
|
| Metabolic Diseases | 1 | 2024 | 658 | 0.590 |
Why?
|
| Mice | 65 | 2024 | 81201 | 0.580 |
Why?
|
| Regeneration | 2 | 2018 | 1485 | 0.570 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2005 | 4554 | 0.550 |
Why?
|
| Echocardiography, Doppler | 1 | 2020 | 935 | 0.550 |
Why?
|
| Mice, Knockout | 22 | 2022 | 14561 | 0.530 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2020 | 857 | 0.530 |
Why?
|
| Myocardial Infarction | 15 | 2023 | 11718 | 0.500 |
Why?
|
| Annexin A5 | 3 | 2009 | 103 | 0.500 |
Why?
|
| Mitochondria, Heart | 5 | 2016 | 247 | 0.500 |
Why?
|
| Disease Models, Animal | 21 | 2024 | 18034 | 0.490 |
Why?
|
| Endothelium, Vascular | 8 | 2013 | 4459 | 0.450 |
Why?
|
| Rats | 25 | 2020 | 24252 | 0.440 |
Why?
|
| Carbocyanines | 3 | 2009 | 174 | 0.440 |
Why?
|
| Reperfusion Injury | 3 | 2017 | 1026 | 0.440 |
Why?
|
| Cardiovascular System | 2 | 2017 | 831 | 0.440 |
Why?
|
| Hypertrophy | 6 | 2017 | 569 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 24 | 2022 | 21833 | 0.420 |
Why?
|
| Models, Cardiovascular | 4 | 2015 | 996 | 0.410 |
Why?
|
| Osteopontin | 1 | 2013 | 294 | 0.410 |
Why?
|
| Cells, Cultured | 28 | 2020 | 19233 | 0.410 |
Why?
|
| Ketone Bodies | 2 | 2021 | 82 | 0.400 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2011 | 63 | 0.400 |
Why?
|
| Nitroso Compounds | 1 | 2011 | 72 | 0.400 |
Why?
|
| I-kappa B Kinase | 2 | 2011 | 252 | 0.390 |
Why?
|
| Atherosclerosis | 2 | 2022 | 3444 | 0.390 |
Why?
|
| Transcription Factors | 11 | 2024 | 12207 | 0.390 |
Why?
|
| Methylococcaceae | 3 | 1997 | 4 | 0.390 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2009 | 2016 | 0.390 |
Why?
|
| Romano-Ward Syndrome | 1 | 2010 | 3 | 0.390 |
Why?
|
| Nitrites | 1 | 2011 | 160 | 0.390 |
Why?
|
| Gene Expression Regulation | 13 | 2020 | 12073 | 0.380 |
Why?
|
| Exercise Tolerance | 1 | 2016 | 768 | 0.380 |
Why?
|
| Cell Transplantation | 1 | 2012 | 477 | 0.370 |
Why?
|
| Cardiovascular Diseases | 6 | 2022 | 15160 | 0.370 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2013 | 851 | 0.350 |
Why?
|
| Ventricular Function, Left | 3 | 2020 | 3666 | 0.350 |
Why?
|
| Enzyme Activation | 6 | 2011 | 3702 | 0.320 |
Why?
|
| Cytokines | 3 | 2023 | 7323 | 0.320 |
Why?
|
| Myocardial Ischemia | 6 | 2017 | 2148 | 0.310 |
Why?
|
| Nitric Oxide | 4 | 2012 | 2132 | 0.310 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 2269 | 0.290 |
Why?
|
| Adenoviridae | 10 | 2005 | 1101 | 0.290 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2009 | 555 | 0.290 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2009 | 262 | 0.280 |
Why?
|
| Fibrosis | 6 | 2020 | 2029 | 0.280 |
Why?
|
| Carrier Proteins | 4 | 2005 | 5023 | 0.270 |
Why?
|
| Animals, Newborn | 8 | 2017 | 2726 | 0.260 |
Why?
|
| Humans | 73 | 2023 | 744366 | 0.250 |
Why?
|
| Ribonucleotide Reductases | 2 | 2001 | 77 | 0.250 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2018 | 2073 | 0.240 |
Why?
|
| Genes, erbB-2 | 1 | 2004 | 162 | 0.240 |
Why?
|
| Endothelial Cells | 6 | 2016 | 3486 | 0.240 |
Why?
|
| Dietary Proteins | 1 | 2009 | 963 | 0.240 |
Why?
|
| Cell Hypoxia | 5 | 2011 | 675 | 0.240 |
Why?
|
| Transgenes | 4 | 2008 | 1009 | 0.240 |
Why?
|
| Gene Deletion | 3 | 2022 | 2751 | 0.240 |
Why?
|
| Stem Cells | 4 | 2009 | 3567 | 0.230 |
Why?
|
| Mice, Transgenic | 13 | 2017 | 9735 | 0.230 |
Why?
|
| Membrane Glycoproteins | 2 | 2024 | 3771 | 0.230 |
Why?
|
| Contrast Media | 5 | 2018 | 5300 | 0.220 |
Why?
|
| Bone Marrow Transplantation | 2 | 2012 | 2765 | 0.220 |
Why?
|
| Cell Proliferation | 8 | 2018 | 10483 | 0.220 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 1888 | 0.220 |
Why?
|
| Blotting, Western | 7 | 2017 | 5181 | 0.220 |
Why?
|
| NF-kappa B | 4 | 2013 | 2499 | 0.210 |
Why?
|
| Cell Survival | 9 | 2017 | 5882 | 0.210 |
Why?
|
| Transforming Growth Factor beta | 3 | 2018 | 2007 | 0.210 |
Why?
|
| Genetic Vectors | 6 | 2004 | 3424 | 0.210 |
Why?
|
| Stem Cell Transplantation | 2 | 2012 | 1620 | 0.210 |
Why?
|
| Cell Division | 4 | 2006 | 4569 | 0.210 |
Why?
|
| Crystallography, X-Ray | 10 | 2001 | 2012 | 0.210 |
Why?
|
| Ischemia | 6 | 2011 | 1907 | 0.200 |
Why?
|
| Gene Transfer Techniques | 3 | 2004 | 1225 | 0.200 |
Why?
|
| Coronary Disease | 2 | 2007 | 6077 | 0.200 |
Why?
|
| Asparagine | 1 | 2001 | 122 | 0.200 |
Why?
|
| Bone Marrow Cells | 3 | 2011 | 2513 | 0.200 |
Why?
|
| Cardiac Resynchronization Therapy | 3 | 2018 | 531 | 0.200 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2020 | 2110 | 0.200 |
Why?
|
| Streptomyces | 1 | 2001 | 89 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 3595 | 0.190 |
Why?
|
| Models, Animal | 2 | 2022 | 2173 | 0.190 |
Why?
|
| Protein Interaction Mapping | 2 | 2017 | 627 | 0.190 |
Why?
|
| Iron | 6 | 2001 | 1774 | 0.190 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2019 | 126 | 0.190 |
Why?
|
| Rodentia | 1 | 2022 | 261 | 0.190 |
Why?
|
| Amidohydrolases | 1 | 2001 | 169 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2014 | 4424 | 0.180 |
Why?
|
| Receptors, LDL | 1 | 2022 | 476 | 0.180 |
Why?
|
| Eye Proteins | 1 | 2024 | 645 | 0.180 |
Why?
|
| Phenylephrine | 3 | 2006 | 301 | 0.180 |
Why?
|
| Phenotype | 8 | 2020 | 16367 | 0.180 |
Why?
|
| Heart Ventricles | 6 | 2019 | 3817 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2017 | 2917 | 0.180 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2016 | 246 | 0.180 |
Why?
|
| Necrosis | 4 | 2013 | 1643 | 0.180 |
Why?
|
| Regional Blood Flow | 2 | 2011 | 1525 | 0.180 |
Why?
|
| Copper | 2 | 1999 | 366 | 0.180 |
Why?
|
| KCNQ1 Potassium Channel | 2 | 2010 | 104 | 0.180 |
Why?
|
| Zebrafish | 4 | 2022 | 2996 | 0.180 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2009 | 430 | 0.170 |
Why?
|
| Gene Targeting | 1 | 2003 | 880 | 0.170 |
Why?
|
| Caspase 3 | 3 | 2009 | 758 | 0.170 |
Why?
|
| Molecular Chaperones | 2 | 2005 | 743 | 0.170 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2009 | 644 | 0.170 |
Why?
|
| Inflammation | 4 | 2022 | 10637 | 0.170 |
Why?
|
| Phosphorylation | 7 | 2013 | 8436 | 0.170 |
Why?
|
| Follistatin-Related Proteins | 1 | 2019 | 48 | 0.170 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2010 | 1736 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2013 | 2916 | 0.170 |
Why?
|
| Echocardiography | 5 | 2018 | 5099 | 0.160 |
Why?
|
| Cholesterol | 2 | 2022 | 2919 | 0.160 |
Why?
|
| Lipopolysaccharides | 2 | 2006 | 2216 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 11726 | 0.160 |
Why?
|
| Male | 40 | 2020 | 350115 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2022 | 783 | 0.160 |
Why?
|
| Glucose | 3 | 2023 | 4398 | 0.150 |
Why?
|
| Protein Kinases | 1 | 2005 | 1640 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 4751 | 0.150 |
Why?
|
| Protein Structure, Secondary | 4 | 2001 | 1247 | 0.150 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2019 | 1335 | 0.150 |
Why?
|
| Ligands | 4 | 2019 | 3282 | 0.150 |
Why?
|
| Mammals | 1 | 2022 | 1143 | 0.150 |
Why?
|
| Muscle Proteins | 3 | 2015 | 1158 | 0.150 |
Why?
|
| Enzyme Induction | 3 | 2014 | 475 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2002 | 3921 | 0.140 |
Why?
|
| Caspases | 3 | 2005 | 928 | 0.140 |
Why?
|
| Constriction, Pathologic | 2 | 2019 | 1107 | 0.140 |
Why?
|
| Enalapril | 1 | 2018 | 327 | 0.140 |
Why?
|
| Superoxide Dismutase | 1 | 1999 | 596 | 0.140 |
Why?
|
| Ureteral Obstruction | 1 | 2018 | 296 | 0.140 |
Why?
|
| Pyruvic Acid | 1 | 2017 | 200 | 0.140 |
Why?
|
| Heart Failure, Systolic | 1 | 2018 | 126 | 0.140 |
Why?
|
| Pressure | 2 | 2019 | 1203 | 0.140 |
Why?
|
| Systole | 1 | 2019 | 958 | 0.140 |
Why?
|
| Cell Cycle Proteins | 5 | 2016 | 3464 | 0.130 |
Why?
|
| S100 Proteins | 1 | 2016 | 259 | 0.130 |
Why?
|
| Muscle Development | 1 | 2017 | 271 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2865 | 0.130 |
Why?
|
| Diastole | 1 | 2018 | 791 | 0.130 |
Why?
|
| Cell Enlargement | 1 | 2015 | 61 | 0.130 |
Why?
|
| Blood Proteins | 1 | 2020 | 1124 | 0.130 |
Why?
|
| Granulocyte-Macrophage Progenitor Cells | 2 | 2011 | 21 | 0.130 |
Why?
|
| STAT1 Transcription Factor | 1 | 2016 | 320 | 0.130 |
Why?
|
| Monocytes | 2 | 2018 | 2596 | 0.120 |
Why?
|
| Receptor, erbB-2 | 1 | 2004 | 2417 | 0.120 |
Why?
|
| High Mobility Group Proteins | 2 | 2014 | 187 | 0.120 |
Why?
|
| Fish Oils | 1 | 2018 | 470 | 0.120 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2014 | 103 | 0.120 |
Why?
|
| Homeodomain Proteins | 1 | 2024 | 2418 | 0.120 |
Why?
|
| Microscopy, Confocal | 3 | 2017 | 1970 | 0.120 |
Why?
|
| Potassium Channels | 2 | 2010 | 563 | 0.120 |
Why?
|
| Myeloid Progenitor Cells | 2 | 2011 | 111 | 0.120 |
Why?
|
| Sodium Channel Blockers | 2 | 2012 | 176 | 0.120 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 2006 | 177 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 4 | 2013 | 2638 | 0.120 |
Why?
|
| Genome, Human | 1 | 2007 | 4420 | 0.120 |
Why?
|
| Sirtuin 2 | 1 | 2014 | 97 | 0.120 |
Why?
|
| Methane | 1 | 1993 | 51 | 0.120 |
Why?
|
| Culture Media, Serum-Free | 2 | 2005 | 158 | 0.120 |
Why?
|
| I-kappa B Proteins | 2 | 2005 | 225 | 0.120 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 9647 | 0.120 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 1790 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 2219 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2018 | 35425 | 0.110 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2015 | 144 | 0.110 |
Why?
|
| Lipodystrophy | 1 | 2014 | 147 | 0.110 |
Why?
|
| Nuclear Proteins | 2 | 2005 | 5856 | 0.110 |
Why?
|
| Sirtuin 3 | 2 | 2010 | 68 | 0.110 |
Why?
|
| Models, Molecular | 8 | 2010 | 5451 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 1999 | 1887 | 0.110 |
Why?
|
| Cell Communication | 1 | 2020 | 1621 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2005 | 1801 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2012 | 55 | 0.110 |
Why?
|
| Transfection | 5 | 2016 | 5895 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2016 | 8300 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2012 | 1988 | 0.110 |
Why?
|
| RNA, Messenger | 5 | 2014 | 13035 | 0.110 |
Why?
|
| Fibroblasts | 2 | 2020 | 4162 | 0.110 |
Why?
|
| Trans-Activators | 3 | 2008 | 2926 | 0.100 |
Why?
|
| Insulin | 4 | 2009 | 6582 | 0.100 |
Why?
|
| Protein Conformation | 3 | 2010 | 4010 | 0.100 |
Why?
|
| Consensus Sequence | 1 | 2012 | 378 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2006 | 565 | 0.100 |
Why?
|
| DNA, Complementary | 4 | 2004 | 2050 | 0.100 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 11366 | 0.100 |
Why?
|
| Angiogenic Proteins | 1 | 2012 | 104 | 0.100 |
Why?
|
| Early Growth Response Transcription Factors | 1 | 2011 | 29 | 0.100 |
Why?
|
| Adipose Tissue, White | 1 | 2014 | 351 | 0.100 |
Why?
|
| Autophagy | 2 | 2017 | 1297 | 0.100 |
Why?
|
| Ventricular Myosins | 1 | 2011 | 50 | 0.100 |
Why?
|
| Acetanilides | 1 | 2012 | 168 | 0.100 |
Why?
|
| Mixed Function Oxygenases | 1 | 1992 | 272 | 0.100 |
Why?
|
| Calcium Signaling | 1 | 2016 | 721 | 0.100 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2011 | 28 | 0.100 |
Why?
|
| Oxidation-Reduction | 4 | 2021 | 2184 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 697 | 0.100 |
Why?
|
| Cyclophilins | 1 | 2010 | 46 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2003 | 1912 | 0.100 |
Why?
|
| Cytosol | 2 | 2005 | 901 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1 | 2 | 2008 | 198 | 0.100 |
Why?
|
| Sodium | 2 | 2022 | 1622 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2014 | 596 | 0.090 |
Why?
|
| Gene Expression Profiling | 4 | 2016 | 9445 | 0.090 |
Why?
|
| Amino Acid Sequence | 7 | 2010 | 13814 | 0.090 |
Why?
|
| Up-Regulation | 4 | 2018 | 4222 | 0.090 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2013 | 314 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2001 | 2751 | 0.090 |
Why?
|
| Immunoblotting | 2 | 2005 | 1683 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2011 | 689 | 0.090 |
Why?
|
| Ion Channel Gating | 1 | 2012 | 437 | 0.090 |
Why?
|
| Molecular Sequence Data | 8 | 2010 | 18111 | 0.090 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2011 | 202 | 0.090 |
Why?
|
| Physical Fitness | 1 | 2014 | 732 | 0.090 |
Why?
|
| Gadolinium DTPA | 2 | 2013 | 836 | 0.090 |
Why?
|
| 4-Chloro-7-nitrobenzofurazan | 1 | 2009 | 19 | 0.090 |
Why?
|
| Binding Sites | 6 | 2001 | 6111 | 0.090 |
Why?
|
| Annexins | 1 | 2009 | 38 | 0.090 |
Why?
|
| Macrophages | 3 | 2018 | 5660 | 0.090 |
Why?
|
| Protein Subunits | 2 | 2004 | 959 | 0.090 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2010 | 154 | 0.090 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2009 | 563 | 0.090 |
Why?
|
| Pentetic Acid | 1 | 2009 | 213 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 7721 | 0.090 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2009 | 250 | 0.090 |
Why?
|
| Mitochondria | 3 | 2014 | 3514 | 0.090 |
Why?
|
| Piperazines | 2 | 2012 | 2488 | 0.080 |
Why?
|
| Proteomics | 2 | 2020 | 3638 | 0.080 |
Why?
|
| Cell Line | 6 | 2011 | 16000 | 0.080 |
Why?
|
| Electrocardiography | 3 | 2012 | 6442 | 0.080 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2009 | 66 | 0.080 |
Why?
|
| Nanotechnology | 3 | 2009 | 710 | 0.080 |
Why?
|
| Stress, Mechanical | 2 | 2005 | 1686 | 0.080 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 5035 | 0.080 |
Why?
|
| NAD | 2 | 2014 | 590 | 0.080 |
Why?
|
| Myofibrils | 1 | 2009 | 146 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 504 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3617 | 0.080 |
Why?
|
| Hypertension | 6 | 2018 | 8479 | 0.080 |
Why?
|
| Age Factors | 3 | 2016 | 18373 | 0.080 |
Why?
|
| Energy Transfer | 1 | 2008 | 109 | 0.080 |
Why?
|
| Adipose Tissue, Brown | 1 | 2014 | 756 | 0.080 |
Why?
|
| Thyroid Hormones | 1 | 2011 | 390 | 0.080 |
Why?
|
| Hydroxylation | 3 | 2001 | 141 | 0.080 |
Why?
|
| Proteins | 1 | 2003 | 6100 | 0.080 |
Why?
|
| Perfusion | 3 | 2012 | 1360 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2005 | 1434 | 0.080 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 496 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2016 | 2967 | 0.080 |
Why?
|
| Heart Failure, Diastolic | 1 | 2008 | 69 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 15520 | 0.080 |
Why?
|
| Adiponectin | 2 | 2014 | 1101 | 0.080 |
Why?
|
| Phosphoproteins | 3 | 2005 | 2441 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 9274 | 0.080 |
Why?
|
| Cell Nucleus | 3 | 2007 | 2969 | 0.080 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 440 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2011 | 644 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2011 | 547 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 627 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2006 | 534 | 0.070 |
Why?
|
| Cell Differentiation | 3 | 2015 | 11486 | 0.070 |
Why?
|
| Time Factors | 10 | 2016 | 40075 | 0.070 |
Why?
|
| Liver | 1 | 2022 | 7475 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2009 | 2887 | 0.070 |
Why?
|
| Spin Labels | 1 | 2008 | 332 | 0.070 |
Why?
|
| Oxidative Stress | 3 | 2017 | 3084 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2016 | 3511 | 0.070 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2011 | 703 | 0.070 |
Why?
|
| Heart Injuries | 1 | 2008 | 210 | 0.070 |
Why?
|
| Factor XIII Deficiency | 1 | 2006 | 16 | 0.070 |
Why?
|
| Tomography, Optical | 1 | 2007 | 126 | 0.070 |
Why?
|
| Longevity | 1 | 2014 | 1071 | 0.070 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2006 | 49 | 0.070 |
Why?
|
| Catalysis | 3 | 2001 | 762 | 0.070 |
Why?
|
| Action Potentials | 2 | 2010 | 1806 | 0.070 |
Why?
|
| Bone Development | 1 | 2009 | 483 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2001 | 2839 | 0.070 |
Why?
|
| Myosin Heavy Chains | 2 | 2011 | 414 | 0.070 |
Why?
|
| Adenosine Triphosphate | 2 | 2023 | 2027 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2009 | 6366 | 0.070 |
Why?
|
| Organometallic Compounds | 1 | 2009 | 665 | 0.070 |
Why?
|
| Chromatography, Liquid | 1 | 2009 | 976 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 17446 | 0.070 |
Why?
|
| Cardiac Output, Low | 1 | 2006 | 195 | 0.070 |
Why?
|
| Hexokinase | 1 | 2005 | 124 | 0.070 |
Why?
|
| Biotransformation | 1 | 2005 | 168 | 0.070 |
Why?
|
| Antibodies | 1 | 2013 | 2460 | 0.060 |
Why?
|
| Homeostasis | 2 | 2018 | 3339 | 0.060 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2005 | 193 | 0.060 |
Why?
|
| Risk Factors | 5 | 2016 | 72296 | 0.060 |
Why?
|
| Glycogen | 1 | 2005 | 259 | 0.060 |
Why?
|
| Flow Cytometry | 4 | 2009 | 5974 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2002 | 205 | 0.060 |
Why?
|
| Deoxyglucose | 1 | 2005 | 337 | 0.060 |
Why?
|
| Magnetics | 1 | 2008 | 606 | 0.060 |
Why?
|
| Female | 20 | 2020 | 380193 | 0.060 |
Why?
|
| Fungal Proteins | 2 | 1999 | 912 | 0.060 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2005 | 78 | 0.060 |
Why?
|
| Escherichia coli | 3 | 2001 | 4217 | 0.060 |
Why?
|
| Aged | 10 | 2020 | 163288 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 300 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2005 | 391 | 0.060 |
Why?
|
| DNA Fragmentation | 1 | 2005 | 242 | 0.060 |
Why?
|
| Cell Movement | 3 | 2013 | 5218 | 0.060 |
Why?
|
| Co-Repressor Proteins | 1 | 2005 | 194 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2200 | 0.060 |
Why?
|
| Muscle, Skeletal | 7 | 2011 | 4925 | 0.060 |
Why?
|
| Cell Fractionation | 1 | 2004 | 252 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2011 | 5867 | 0.060 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2005 | 215 | 0.060 |
Why?
|
| Diabetic Angiopathies | 1 | 2009 | 818 | 0.060 |
Why?
|
| Cell Count | 2 | 2005 | 1856 | 0.060 |
Why?
|
| Methylococcus capsulatus | 2 | 2001 | 8 | 0.060 |
Why?
|
| Hydrogen Bonding | 2 | 2001 | 291 | 0.060 |
Why?
|
| Myosin Light Chains | 1 | 2004 | 121 | 0.060 |
Why?
|
| Thyroid Gland | 1 | 2011 | 1173 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15535 | 0.060 |
Why?
|
| Tachycardia, Ventricular | 1 | 2012 | 1273 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2009 | 1438 | 0.060 |
Why?
|
| Fasting | 2 | 2007 | 1592 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2010 | 1723 | 0.060 |
Why?
|
| Antigens, CD34 | 1 | 2005 | 659 | 0.060 |
Why?
|
| Tibia | 1 | 2009 | 1077 | 0.060 |
Why?
|
| Myocarditis | 1 | 2011 | 771 | 0.060 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 1725 | 0.060 |
Why?
|
| Androstadienes | 1 | 2005 | 345 | 0.060 |
Why?
|
| bcl-X Protein | 1 | 2004 | 411 | 0.060 |
Why?
|
| Structure-Activity Relationship | 3 | 2010 | 3130 | 0.060 |
Why?
|
| Biosensing Techniques | 1 | 2009 | 668 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2001 | 7182 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2011 | 1350 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2013 | 3390 | 0.060 |
Why?
|
| Insulin Resistance | 2 | 2014 | 3864 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2008 | 1125 | 0.050 |
Why?
|
| Adult | 9 | 2020 | 214052 | 0.050 |
Why?
|
| Kinetics | 3 | 2009 | 6476 | 0.050 |
Why?
|
| Phospholipases A | 1 | 2003 | 216 | 0.050 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2002 | 27 | 0.050 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2002 | 68 | 0.050 |
Why?
|
| Multipotent Stem Cells | 1 | 2004 | 186 | 0.050 |
Why?
|
| RNA, Complementary | 1 | 2002 | 45 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2002 | 707 | 0.050 |
Why?
|
| X-Ray Diffraction | 2 | 1993 | 420 | 0.050 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2013 | 1632 | 0.050 |
Why?
|
| Coronary Circulation | 1 | 2008 | 1572 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 906 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2005 | 880 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2002 | 27 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 443 | 0.050 |
Why?
|
| Organ Size | 3 | 2018 | 2251 | 0.050 |
Why?
|
| Thymidine | 1 | 2022 | 310 | 0.050 |
Why?
|
| Catalytic Domain | 2 | 2001 | 698 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2003 | 171 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2002 | 188 | 0.050 |
Why?
|
| Ketones | 1 | 2023 | 188 | 0.050 |
Why?
|
| Clavulanic Acid | 1 | 2001 | 19 | 0.050 |
Why?
|
| Flavonoids | 1 | 2005 | 443 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2002 | 190 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2002 | 195 | 0.050 |
Why?
|
| Aspartate-Ammonia Ligase | 1 | 2001 | 16 | 0.050 |
Why?
|
| Risk | 2 | 2020 | 9688 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2003 | 314 | 0.050 |
Why?
|
| Hydrocarbons, Iodinated | 1 | 2001 | 10 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 913 | 0.050 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2001 | 28 | 0.050 |
Why?
|
| Paracrine Communication | 1 | 2003 | 278 | 0.050 |
Why?
|
| Cross-Linking Reagents | 1 | 2004 | 694 | 0.050 |
Why?
|
| Toll-Like Receptors | 1 | 2005 | 593 | 0.050 |
Why?
|
| Calcineurin | 1 | 2022 | 226 | 0.050 |
Why?
|
| Cell Size | 2 | 2013 | 643 | 0.050 |
Why?
|
| Alkanes | 1 | 2001 | 45 | 0.050 |
Why?
|
| Cell Adhesion | 3 | 2004 | 3144 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2003 | 369 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2010 | 2566 | 0.050 |
Why?
|
| Static Electricity | 1 | 2001 | 263 | 0.050 |
Why?
|
| Nanoparticles | 2 | 2009 | 1905 | 0.050 |
Why?
|
| Xenon | 1 | 2001 | 110 | 0.050 |
Why?
|
| Cell Membrane | 3 | 2005 | 3749 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1092 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 915 | 0.050 |
Why?
|
| Feedback, Physiological | 1 | 2003 | 479 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 563 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 494 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5534 | 0.050 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2003 | 390 | 0.050 |
Why?
|
| Cell Death | 2 | 2006 | 1707 | 0.050 |
Why?
|
| Genotype | 2 | 2013 | 12952 | 0.050 |
Why?
|
| DNA | 3 | 2012 | 7294 | 0.050 |
Why?
|
| Leucine | 2 | 2002 | 560 | 0.050 |
Why?
|
| Dimerization | 1 | 2001 | 895 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2001 | 2256 | 0.040 |
Why?
|
| E-Selectin | 1 | 2002 | 579 | 0.040 |
Why?
|
| Hindlimb | 2 | 2011 | 504 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 2088 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 2038 | 0.040 |
Why?
|
| Gene Expression | 3 | 2011 | 7798 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2003 | 622 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2017 | 63107 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 57776 | 0.040 |
Why?
|
| Middle Aged | 10 | 2019 | 213390 | 0.040 |
Why?
|
| Metalloproteins | 2 | 2000 | 100 | 0.040 |
Why?
|
| Wound Healing | 2 | 2008 | 2785 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2009 | 2576 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2005 | 850 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 1312 | 0.040 |
Why?
|
| Dependovirus | 1 | 2003 | 706 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 4386 | 0.040 |
Why?
|
| Calcium | 3 | 2006 | 5755 | 0.040 |
Why?
|
| Magnesium | 1 | 2001 | 813 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 1159 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3873 | 0.040 |
Why?
|
| RNA, Small Untranslated | 1 | 2018 | 76 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2005 | 6621 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 2001 | 1802 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 1340 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 871 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2009 | 2737 | 0.040 |
Why?
|
| Pregnancy | 2 | 2017 | 29144 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1284 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2001 | 3848 | 0.040 |
Why?
|
| Crystallization | 2 | 2001 | 525 | 0.040 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2016 | 33 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 3799 | 0.040 |
Why?
|
| Swine | 2 | 2023 | 5918 | 0.030 |
Why?
|
| Citric Acid Cycle | 1 | 2017 | 232 | 0.030 |
Why?
|
| Bone Density | 1 | 2009 | 3468 | 0.030 |
Why?
|
| Heart Atria | 1 | 2022 | 1356 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2009 | 4463 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2000 | 1079 | 0.030 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2016 | 72 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 9955 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 3 | 2009 | 2700 | 0.030 |
Why?
|
| Mice, Inbred NOD | 2 | 2011 | 1879 | 0.030 |
Why?
|
| Temperature | 1 | 2002 | 2204 | 0.030 |
Why?
|
| Base Sequence | 4 | 2011 | 12797 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2013 | 1547 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2005 | 2926 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2009 | 6254 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 437 | 0.030 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2014 | 38 | 0.030 |
Why?
|
| Histones | 1 | 2005 | 2598 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2006 | 2943 | 0.030 |
Why?
|
| Endosomes | 1 | 2017 | 519 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 29060 | 0.030 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2014 | 96 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2002 | 1609 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2020 | 8551 | 0.030 |
Why?
|
| Leukocytes | 1 | 2002 | 2045 | 0.030 |
Why?
|
| RNA Interference | 2 | 2016 | 2890 | 0.030 |
Why?
|
| Rats, Nude | 1 | 2013 | 105 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2009 | 1828 | 0.030 |
Why?
|
| Histidine | 1 | 1994 | 313 | 0.030 |
Why?
|
| Neuregulin-1 | 1 | 2014 | 142 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2016 | 927 | 0.030 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2013 | 254 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2022 | 2108 | 0.030 |
Why?
|
| Progesterone | 1 | 2017 | 775 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 1865 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 295 | 0.030 |
Why?
|
| Cell Shape | 1 | 2014 | 375 | 0.030 |
Why?
|
| Vascular System Injuries | 1 | 2016 | 250 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2001 | 1939 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 19905 | 0.030 |
Why?
|
| Mutation | 6 | 2010 | 29786 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2020 | 2019 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2018 | 1200 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 5524 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2017 | 1132 | 0.030 |
Why?
|
| Body Water | 1 | 2013 | 343 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2015 | 493 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1516 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 10252 | 0.020 |
Why?
|
| Mitochondrial Swelling | 1 | 2010 | 17 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1993 | 419 | 0.020 |
Why?
|
| Genomics | 1 | 2007 | 5717 | 0.020 |
Why?
|
| Ligation | 1 | 2012 | 453 | 0.020 |
Why?
|
| Cardiology | 1 | 2002 | 1668 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1993 | 1454 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2009 | 1793 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2014 | 881 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2011 | 117 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 2011 | 210 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2020 | 2575 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2023 | 3296 | 0.020 |
Why?
|
| Blood Circulation | 1 | 2011 | 251 | 0.020 |
Why?
|
| Dogs | 1 | 2015 | 3912 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2021 | 2897 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2010 | 386 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2016 | 1539 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2017 | 1809 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2013 | 5984 | 0.020 |
Why?
|
| Cisplatin | 1 | 1995 | 1662 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2009 | 266 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2011 | 494 | 0.020 |
Why?
|
| Cyclin E | 1 | 2009 | 172 | 0.020 |
Why?
|
| Microvessels | 1 | 2013 | 544 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 500 | 0.020 |
Why?
|
| Isotopes | 1 | 2008 | 124 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2428 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2006 | 13693 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 2009 | 259 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2018 | 2073 | 0.020 |
Why?
|
| Software | 1 | 2002 | 4441 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2009 | 185 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6171 | 0.020 |
Why?
|
| Methyl Methanesulfonate | 1 | 2007 | 27 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2010 | 788 | 0.020 |
Why?
|
| Coronary Sinus | 1 | 2008 | 87 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1084 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3130 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1707 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 2008 | 287 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4208 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2009 | 349 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1341 | 0.020 |
Why?
|
| Food Deprivation | 1 | 2007 | 116 | 0.020 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2007 | 86 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2011 | 794 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 895 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2011 | 849 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2009 | 599 | 0.020 |
Why?
|
| Thyroxine | 1 | 2011 | 667 | 0.020 |
Why?
|
| Mutagens | 1 | 2007 | 168 | 0.020 |
Why?
|
| Fluorescence | 1 | 2009 | 751 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 964 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2008 | 360 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 1950 | 0.020 |
Why?
|
| Autoantigens | 1 | 2011 | 892 | 0.020 |
Why?
|
| Research Design | 1 | 2002 | 5984 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 2891 | 0.020 |
Why?
|
| Vibration | 1 | 2008 | 326 | 0.020 |
Why?
|
| Factor XIII | 1 | 2006 | 59 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2006 | 158 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2011 | 1267 | 0.020 |
Why?
|
| Lysine | 1 | 2010 | 1007 | 0.020 |
Why?
|
| Endothelium | 1 | 2008 | 778 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2009 | 1308 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2006 | 425 | 0.020 |
Why?
|
| Adolescent | 2 | 2011 | 85779 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2006 | 180 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 2011 | 658 | 0.020 |
Why?
|
| Infant | 2 | 2022 | 35134 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 504 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 10183 | 0.020 |
Why?
|
| Mitochondrial Membranes | 1 | 2006 | 174 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 3773 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 972 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 2120 | 0.020 |
Why?
|
| Reference Standards | 1 | 2008 | 1025 | 0.020 |
Why?
|
| Sirtuins | 1 | 2007 | 323 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2006 | 590 | 0.020 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2013 | 1265 | 0.020 |
Why?
|
| LLC-PK1 Cells | 1 | 2004 | 132 | 0.020 |
Why?
|
| Ion Channels | 1 | 2009 | 1056 | 0.010 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2004 | 90 | 0.010 |
Why?
|
| Weight Gain | 1 | 2014 | 2293 | 0.010 |
Why?
|
| Nuclear Localization Signals | 1 | 2004 | 80 | 0.010 |
Why?
|
| Computational Biology | 1 | 2016 | 3519 | 0.010 |
Why?
|
| Troponin T | 1 | 2009 | 754 | 0.010 |
Why?
|
| Microcirculation | 1 | 2008 | 1287 | 0.010 |
Why?
|
| Genes, Synthetic | 1 | 2004 | 90 | 0.010 |
Why?
|
| Comet Assay | 1 | 2003 | 71 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 2003 | 203 | 0.010 |
Why?
|
| Muramidase | 1 | 2003 | 174 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5077 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 323 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 675 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2006 | 1137 | 0.010 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2009 | 964 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2006 | 1105 | 0.010 |
Why?
|
| Adenoviridae Infections | 1 | 2003 | 96 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 365 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2007 | 1536 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2013 | 4196 | 0.010 |
Why?
|
| Epinephrine | 1 | 2006 | 792 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 852 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2009 | 3689 | 0.010 |
Why?
|
| Genes, myc | 1 | 2004 | 399 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2009 | 1443 | 0.010 |
Why?
|
| Child | 1 | 2010 | 77709 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2003 | 251 | 0.010 |
Why?
|
| Spectroscopy, Mossbauer | 1 | 2001 | 2 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2006 | 839 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2011 | 2259 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 733 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8319 | 0.010 |
Why?
|
| COS Cells | 1 | 2004 | 1161 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2003 | 434 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2006 | 571 | 0.010 |
Why?
|
| Water | 1 | 2008 | 1395 | 0.010 |
Why?
|
| Oxygen Isotopes | 1 | 2001 | 44 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2003 | 743 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2006 | 850 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 1581 | 0.010 |
Why?
|
| Cyclins | 1 | 2004 | 603 | 0.010 |
Why?
|
| P-Selectin | 1 | 2004 | 601 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 3554 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 994 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2008 | 1359 | 0.010 |
Why?
|
| Pedigree | 1 | 2009 | 4642 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 12262 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13286 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 1 | 2013 | 1965 | 0.010 |
Why?
|
| Reference Values | 1 | 2008 | 4982 | 0.010 |
Why?
|
| Benzamides | 1 | 2006 | 1379 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 705 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2010 | 3203 | 0.010 |
Why?
|
| X-Rays | 1 | 2001 | 301 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2012 | 3107 | 0.010 |
Why?
|
| Peripheral Arterial Disease | 1 | 2011 | 1188 | 0.010 |
Why?
|
| Freezing | 1 | 2001 | 303 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6486 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 6386 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 12746 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 20952 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 1263 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 2480 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 8949 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2008 | 2190 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 2646 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2003 | 973 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2004 | 1549 | 0.010 |
Why?
|
| Electron Transport | 1 | 2000 | 211 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 56429 | 0.010 |
Why?
|
| Solubility | 1 | 2001 | 1088 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 2001 | 454 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2002 | 619 | 0.010 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2001 | 247 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2003 | 1035 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2004 | 2008 | 0.010 |
Why?
|
| Telomerase | 1 | 2004 | 730 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 3001 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2003 | 1227 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2008 | 2948 | 0.010 |
Why?
|
| Aorta | 1 | 2006 | 2062 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 3505 | 0.010 |
Why?
|
| Body Weight | 1 | 2009 | 4671 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 3759 | 0.010 |
Why?
|
| Telomere | 1 | 2004 | 910 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2000 | 1202 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 686 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 2076 | 0.010 |
Why?
|
| Oxygen | 1 | 2008 | 4189 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 3326 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 4042 | 0.010 |
Why?
|
| DNA Adducts | 1 | 1995 | 93 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2002 | 1837 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2004 | 2504 | 0.010 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1994 | 165 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 4320 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10943 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 53290 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 3508 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 2850 | 0.010 |
Why?
|
| Neutrophils | 1 | 2006 | 3721 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2004 | 2949 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 2455 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14723 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 13882 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1995 | 913 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1994 | 626 | 0.010 |
Why?
|
| Antioxidants | 1 | 1999 | 1659 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1995 | 1899 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 25628 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2003 | 5096 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 9384 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2001 | 6194 | 0.000 |
Why?
|
| Neoplasms | 1 | 2008 | 21696 | 0.000 |
Why?
|